44th week of 2017 patent applcation highlights part 8 |
Patent application number | Title | Published |
20170312236 | PHARMACEUTICAL COMPOSITIONS OF FLURBIPROFEN AND TRAMADOL | 2017-11-02 |
20170312237 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TISSUE SELF-REPAIR AND REGENERATION | 2017-11-02 |
20170312238 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | 2017-11-02 |
20170312239 | COMPOUNDS AND THEIR SALTS SPECIFIC TO THE PPAR RECEPTORS AND THE EGF RECEPTORS AND THEIR USE IN THE MEDICAL FIELD | 2017-11-02 |
20170312240 | COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS | 2017-11-02 |
20170312241 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | 2017-11-02 |
20170312242 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | 2017-11-02 |
20170312243 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | 2017-11-02 |
20170312244 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING TAXANE | 2017-11-02 |
20170312245 | TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF | 2017-11-02 |
20170312246 | LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR USE IN THE TREATMENT OF ATROPHIC VAGINITIS | 2017-11-02 |
20170312247 | HERIPENES WITH PAIN-RELIEVING EFFECT, ACTIVE SUBSTANCES OF Hericium erinaceus MYCELIUM AND THE PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE HERIPENES OR ACTIVE SUBSTANCES | 2017-11-02 |
20170312248 | PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND ADP RECEPTOR ANTAGONIST, PREPARATION METHOD THEREOF AND USE THEREOF | 2017-11-02 |
20170312249 | MODULATORS OF 14-3-3 FUNCTIONALITY AND USES THEREOF | 2017-11-02 |
20170312250 | Melanin Compositions and Devices for Protecting Tissues from Radiation Damage | 2017-11-02 |
20170312251 | NUTRITIONAL SUPPLEMENTS FOR IMPROVING FEMALE FERTILITY | 2017-11-02 |
20170312252 | PYRROLIDINE AMIDE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS | 2017-11-02 |
20170312253 | METHODS OF PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) WITH AN EDARAVONE MEDICAMENT | 2017-11-02 |
20170312254 | Low Dose Pharmaceutical Composition | 2017-11-02 |
20170312255 | IFETROBAN TREATMENT FOR SYSTEMIC SCLEROSIS | 2017-11-02 |
20170312256 | TRANSDERMAL PARASITICIDAL FORMULATIONS | 2017-11-02 |
20170312257 | TREATMENT OF ZIKA VIRUS INFECTIONS USING ALPHA-GLUCOSIDASE INHIBITORS | 2017-11-02 |
20170312259 | METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA | 2017-11-02 |
20170312260 | NEW INDICATION OF AZELNIDIPINE PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | 2017-11-02 |
20170312261 | CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS AND NICOTINE | 2017-11-02 |
20170312262 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | 2017-11-02 |
20170312263 | SUBSTITUTED NAPHTHYRIDINE AND QUINOLINE COMPOUNDS AS MAO INHIBITORS | 2017-11-02 |
20170312264 | USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION | 2017-11-02 |
20170312265 | METHOD FOR IMPROVING INTERSTITIAL FLOW | 2017-11-02 |
20170312266 | METHOD OF ISOLATING PHENANTHROINDOLIZIDINE ALKALOIDS FROM TYLOPHORA ATROFOLLICULATA WITH HIF-1 INHIBITORY ACTIVITY, COMPOSITIONS COMPRISING THEM AND THEIR USE | 2017-11-02 |
20170312267 | METHOD OF ISOLATING PHENANTHROINDOLIZIDINE ALKALOIDS FROM TYLOPHORA ATROFOLLICULATA, COMPOSITIONS COMPRISING THEM AND THEIR MEDICAL USE | 2017-11-02 |
20170312268 | METHODS FOR TREATING A NEUROLOGICAL DISORDER IN A SUBJECT USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) PROYL HYDROXYLASE | 2017-11-02 |
20170312269 | COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS | 2017-11-02 |
20170312270 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | 2017-11-02 |
20170312271 | CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS | 2017-11-02 |
20170312272 | TEMOZOLOMIDE POWDER FORMULATION | 2017-11-02 |
20170312273 | METHODS OF USING FASN INHIBITORS | 2017-11-02 |
20170312274 | METHOD FOR TREATING A BRAIN TUMOUR | 2017-11-02 |
20170312275 | COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS | 2017-11-02 |
20170312276 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | 2017-11-02 |
20170312277 | Compounds for Treatment of Fibrosis Diseases | 2017-11-02 |
20170312278 | METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY COMPRISING ADMINISTERING SUBSTITUTED PYRAZINO[2,3-b]PYRAZINES | 2017-11-02 |
20170312279 | 1-PYRAZOLYL-3-(4-((2-ANILINOPYRIMIDIN-4 -YL) OXY) NAPTHTHALEN-1 - YL) UREAS AS P38 MAP KNASE INHIBITORS | 2017-11-02 |
20170312280 | PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS | 2017-11-02 |
20170312281 | METHOTREXATE FORMULATION | 2017-11-02 |
20170312282 | TYROSINE KINASE INHIBITOR FORMULATIONS FOR THE TREATMENT OF MAST CELL-MEDIATED INFLAMMATORY DISEASES AND METHODS OF USE THEREOF | 2017-11-02 |
20170312283 | ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS | 2017-11-02 |
20170312284 | ANALOGS OF ADENOSINE MONOPHOSPHATE (AMP) AS INHIBITORS OF UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME ATG7 | 2017-11-02 |
20170312285 | COMPOUNDS FOR THE TREATMENT OF MYOTONIC DYSTROPHY | 2017-11-02 |
20170312286 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | 2017-11-02 |
20170312287 | DPP IV INHIBITOR FORMULATIONS | 2017-11-02 |
20170312289 | METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION | 2017-11-02 |
20170312290 | FUNCTIONALIZED MORPHOLINYL ANTHRACYCLINE DERIVATIVES | 2017-11-02 |
20170312291 | METHOD OF TREATING MICROBIAL INFECTIONS | 2017-11-02 |
20170312292 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2017-11-02 |
20170312293 | ANTIMICROBIAL WATER DISPERSIBLE COMPOSITION COMPRISING ZINC PYRITHIONE | 2017-11-02 |
20170312294 | COMBINATION OF LUPEOL ACETATE AND CURCUMIN USED FOR THE TREATMENT OR PREVENTION OF OSTEOPOROSIS | 2017-11-02 |
20170312295 | Ophthalmologic Irrigation Solutions and Method | 2017-11-02 |
20170312296 | AGENTS FOR KILLING HIV-1-INFECTED CELLS AND APPLICATION THEREOF | 2017-11-02 |
20170312297 | Long Acting Pharmaceutical Compositions For Hepatitis C | 2017-11-02 |
20170312298 | MIXTURES OF HMOs | 2017-11-02 |
20170312299 | Cellular Delivery of DNA Intercalating Agents | 2017-11-02 |
20170312300 | Methods for Treating Cancer | 2017-11-02 |
20170312301 | SKIN BARRIER FUNCTION-IMPROVING AGENT AND COMPOSITION FOR IMPROVING SKIN BARRIER FUNCTION | 2017-11-02 |
20170312302 | PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER | 2017-11-02 |
20170312303 | COMPOSITIONS COMPRISING CH848 ENVELOPES AND USES THEREOF | 2017-11-02 |
20170312304 | miRNA FOR TREATING CANCER AND FOR USE WITH ADOPTIVE IMMUNOTHERAPIES | 2017-11-02 |
20170312305 | PHARMACEUTICAL EXTRACTS AND USES THEREOF | 2017-11-02 |
20170312306 | SHEAR-THINNING HYDROGEL, KIT AND METHOD OF PREPARATION | 2017-11-02 |
20170312307 | TOPICAL GELS AND METHODS OF USING THE SAME | 2017-11-02 |
20170312308 | XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS | 2017-11-02 |
20170312309 | INTRADIALYTIC ADMINISTRATION OF SODIUM THIOSULFATE | 2017-11-02 |
20170312310 | USE OF NITRITE SALTS IN CHRONIC ISCHEMIA | 2017-11-02 |
20170312311 | COMPOSITION, CONTAINING HIGH-HARDNESS MINERAL WATER PREPARED FROM SALTY UNDERGROUND WATER OR DEEP-SEA WATER, FOR PREVENTING OR ALLEVIATING DECREASE IN BLOOD PRESSURE OR SYMPTOMS RELATED THERETO | 2017-11-02 |
20170312312 | Chlorite-Containing Compositions | 2017-11-02 |
20170312313 | SYNTHESIS OF ULTRA-SMALL CERIA-ZIRCONIA NANOPARTICLES AND CERIA-ZIRCONIA NANO COMPLEX AND ITS APPLICATION AS A THERAPEUTIC AGENT FOR SEPSIS | 2017-11-02 |
20170312314 | SYSTEM FOR TREATING A SEBACEOUS GLAND | 2017-11-02 |
20170312315 | Engineered Dendritic Cells and Uses for the Treatment of Cancer | 2017-11-02 |
20170312316 | CARTILAGE CELLS WITH A HIGH REGENERATIVE POTENTIAL AND LOW IMMUNE RESPONSE FOR USE IN CELLULAR THERAPY | 2017-11-02 |
20170312317 | CELL-BASED THERAPY FOR THE PULMONARY SYSTEM | 2017-11-02 |
20170312318 | METHODS AND COMPOSITIONS FOR IN VIVO INDUCTION OF PANCREATIC BETA CELL FORMATION | 2017-11-02 |
20170312319 | PERICYTES ARE INTERMEDIATE PROGENITORS FOR EPICARDIAL DERIVED CORONARY ARTERY SMOOTH MUSCLE | 2017-11-02 |
20170312320 | BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA | 2017-11-02 |
20170312321 | PROBIOTIC AND PREBIOTIC COMPOSITIONS | 2017-11-02 |
20170312322 | ANTIBACTERIAL AND PROTECTIVE FORMULATIONS AND METHODS FOR MAKING AND USING THEM | 2017-11-02 |
20170312323 | GEL CAPSULE COMPRISING A PLANT CELL | 2017-11-02 |
20170312324 | USE OF MAITAKE AND MAITAKE GRIFOLAN D COMPONENT IN PREPARATION OF ANTIDEPRESSANT DRUG | 2017-11-02 |
20170312326 | Smokeless cannabis composition and method of manufacture | 2017-11-02 |
20170312327 | EXTRACTION DEVICES, SYSTEMS, AND METHODS | 2017-11-02 |
20170312328 | NUTRITIONAL SUPPLEMENTS FOR IMPROVING MALE FERTILITY | 2017-11-02 |
20170312329 | Compositions and Methods for Treatment of Prediabetes | 2017-11-02 |
20170312330 | METHODS OF INCREASING FERTILITY OF A MALE SUBJECT WITH COSTUS SPECIOSUS EXTRACT | 2017-11-02 |
20170312331 | PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT | 2017-11-02 |
20170312332 | INHIBITORS OF MITOCHONDRIAL FISSION AND METHODS OF USE THEREOF | 2017-11-02 |
20170312333 | Composition for Treating Cancer Stem Cells | 2017-11-02 |
20170312334 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS | 2017-11-02 |
20170312335 | TOPICAL USE OF PRG4 FOR TREATMENT OF ALLERGY AND SYMPTOMS OF INFLAMMATION | 2017-11-02 |
20170312336 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER | 2017-11-02 |
20170312337 | METHOD FOR ADMINISTERING OMEGA-CONOPEPTIDE | 2017-11-02 |
20170312338 | USE OF RECOMBINANT LYMPHOCYTE ACTIVATION GENE-3 AS A COMPANION THERAPEUTIC FOR PATIENTS AT RISK FOR CARDIOVASCULAR DISEASE AND OTHER CHRONIC INFLAMMATORY DISEASES | 2017-11-02 |